Etrasimod is a selective sphingosine-1-phosphate (S1P) receptor modulator used as an active pharmaceutical ingredient. It is taken orally and functions by modifying immune system activity, primarily for the management of ulcerative colitis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Etrasimod?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Etrasimod arginine
pharmaceutical raw material
Ethyl 2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate
pharmaceutical intermediate
Gsk-2018682
pharmaceutical raw material
Filgotinib
pharmaceutical raw material
Bromfenac monosodium sesquihydrate
pharmaceutical raw material
Midostaurin
pharmaceutical raw material
(Z)-3-(3-(((4-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindolin-6-yl)-N-ethylpropiolamide
pharmaceutical raw material
(S)-2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid
research compound
The international HS code for Etrasimod (CAS 1206123-37-6) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[(3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid
MVGWUTBTXDYMND-QGZVFWFLSA-N
C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CC[C@@H]5CC(=O)O)C(F)(F)F
Sourcing Etrasimod?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.